Skip to Content
Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 05/01/18

Linda Park, Pharm.D., M.S.

Linda Park, Pharm.D., M.S.

Regulatory Affairs Specialist

Dr. Linda Park joined the Drug Regulatory Group in the Regulatory Affairs Branch (RAB), CTEP in 2018. Prior to joining RAB, Dr. Park spent 8 years at FDA, where she held a number of positions in the Center for Drug Evaluation and Research. She first served as the Regulatory Project Manager in the Office of Generic Drugs where she managed abbreviated new drug applications and served as the liaison between the FDA and Generic Drug Industry. She was also a Regulatory Reviewer in the Office of Prescription Drug Promotion where she reviewed advertising and promotional materials for oncology drugs. Prior to working at the FDA, Dr. Park served as a Post-Doctoral Fellow in Global Regulatory Affairs at Schering-Plough. Dr. Park received her Doctor of Pharmacy degree from Western University of Health Sciences, and her Masterís degree in Regulatory Science from the University of Southern California.

About the Branch Chief

Bhanu Ramineni, M.S., M.S. Bhanu Ramineni, M.S., M.S., became the Chief of the Regulatory Affairs Branch in October 2019. She joined the Drug Regulatory Group in the branch in 2010. She holds two Master's degrees: one in Environmental Sciences from Nagarjuna University, India, and a second one in Biochemistry and Molecular Biology with a specialization in Biotechnology from Georgetown University. Ms. Ramineni comes with significant experience in FDA Regulatory Affairs, as well as preclinical and clinical development of vaccines with a special focus in immunology. More…